Acute Myeloid Leukemia: Clinical Trials

18 trials for Acute Myeloid Leukemia, newest first

ClinicalTrials Daily · Areas · Conditions · Drugs · Sponsors ·

8 unknown, 5 completed, 4 recruiting, 1 active not recruiting. 18 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	18	Unknown 8, Completed 5, Recruiting 4, Active not recruiting 1

Follow Acute Myeloid Leukemia: new trials by email Literature Review of Acute Myeloid Leukemia trials Research Report on Acute Myeloid Leukemia

Trials (filtered) newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India Venetoclax, Azacitidine - Acute Myeloid Leukemia	Phase 4	Recruiting	AbbVie	100	2025-07-24	2026-09-11
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality Oral Azacitidine - Acute Myeloid Leukemia	Phase 4	Recruiting	Virginia Commonwealth University	12	2024-11-07	2026-05-29
RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR Venetoclax, Allogeneic transplant - Acute Myeloid Leukemia	Phase 4	Recruiting	He Huang	118	2024-07-17	2024-08-26
Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy Venetoclax, Azacitidine, Decitabine - Acute Myeloid Leukemia	Phase 4	Completed	Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh	24	2022-06-01	2026-08-21
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3). daunomycin/Idarubicin+ Silybinin, daunomycin/Idarubicin - Acute Myeloid Leukemia, Newly Diagnosed	Phase 4	Recruiting	Fujian Medical University Union Hospital	100	2022-04-01	2026-05-01
Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML Fludarabine, Cytarabine - Acute Myeloid Leukemia, Core-Binding Factor	Phase 4	Completed	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	68	2017-01-01	2024-10-01
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21) Decitabine, Daunorubicin, Cytarabine, Mitoxantrone, Cytarabine - Acute Myeloid Leukemia	Phase 4	Unknown	The First Hospital of Jilin University	180	2017-01-01	2017-01-20
G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor GM-CSF, G-CSF, GM-CSF and G-CSF - Acute Myeloid Leukemia, Acute Lymphoid Leukemia	Phase 4	Unknown	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	405	2016-09-27	2018-10-17
CINC424A2X01B Rollover Protocol ruxolitinib, panobinostat - Primary Myelofibrosis, Polycythemia Vera	Phase 4	Active not recruiting	Novartis Pharmaceuticals	279	2015-03-05	2026-10-19
Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCT Interferon-alpha - Acute Myeloid Leukemia	Phase 4	Unknown	Peking University People's Hospital	40	2013-10-01	2016-09-29
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia Multiplex respiratory viral PCR - Acute Myeloid Leukemia	Phase 4	Completed	Centre Hospitalier Universitaire, Amiens	119	2013-04-01	2018-04-23
AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy Fludarabine, Cytarabine - Acute Myeloid Leukemia, AML1-ETO Fusion Protein Expression	Phase 4	Unknown	Changhai Hospital	62	2010-11-01	2013-12-31
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia Idarubicin(8mg/m2) and cytosine arabinoside, Idarubicin(10mg/m2), cytosine arabinoside - Acute Myeloid Leukemia	Phase 4	Unknown	Guangdong Provincial People's Hospital	400	2010-03-01	2014-10-29
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia high dose ARA-C, standard dose ARA-C - Acute Myeloid Leukemia	Phase 4	Unknown	National Research Center for Hematology, Russia	245	2010-01-01	2014-04-07
Early Tapering of Immunosuppressive Agents to Immunomodulation to Improve Survival of AML Patients Cyclosporine, routine reduction of immunosuppressive drugs(cyclosporine) - Acute Myeloid Leukemia, Disorder Related to Bone Marrow Transplantation	Phase 4	Unknown	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	100	2010-01-01	2017-05-12
Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia histamine dihydrochloride and IL-2 - Acute Myeloid Leukemia	Phase 4	Completed	Cytovia, Inc.	84	2009-07-01	2017-11-29
Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Topotecan, Fludarabine, Cytarabine - Acute Myeloid Leukemia	Phase 4	Completed	PETHEMA Foundation	47	2003-05-01	2008-11-18
Efficacy of G-CSF-Priming in Elderly AML Patients Cytarabine, Etoposide, Idarubicin - Acute Myeloid Leukemia	Phase 4	Unknown	Johann Wolfgang Goethe University Hospital	250	2000-01-01	2005-10-26

Narrower conditions

Broader conditions

Interventions

Sponsors

Countries

Top investigators

Results publications

NIH funding